Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for mycoplasma severity

BACKGROUND Mycoplasma pneumoniae pneumonia(MPP)significantly impacts pediatric health,necessitating markers for early severe disease identification.AIM To investigate the correlation between serum inflammatory marker and the severity of MPP in children.METHODS A prospective study was carried out from January 2023 to November 2023.A total of 160 children with MPP who underwent treatment were selected:80 had severe MPP and 80 had mild MPP.Clinical and laboratory data were collected at the time of hospital admission and during hospitalization.Receiver operating characteristic curves were utilized to assess the diagnostic and prognostic for severe MPP.RESULTS Fever duration and length of hospitalization in pediatric patients with severe MPP exceeded those with mild MPP.The incidence of pleural effusion,lung consolidation,and bronchopneumonia on imaging was markedly elevated in the severe MPP cohort compared to the mild MPP cohort.In contrast to the mild cohort,there was a notable increase in C-reactive protein(CRP),procalcitonin(PCT),erythrocyte sedimentation rate,lactic dehydrogenase,D-dimer,and inflammatory cytokines[interleukin(IL)-6,IL-8,IL-10 and tumor necrosis factor(TNF)-α]in the severe MPP group were significantly higher.CONCLUSION Serum inflammatory markers(CRP,PCT,IL-6,D-dimer,IL-10 and TNF-α)were considered as predictors in children with severe MPP.

Intestinal Microecology in Children with Pneumonia: The Relationship Between Digestive Health and Disease Recovery

This paper explores the association between intestinal microecology and digestive health and disease recovery in children with pneumonia.Intestinal microecological imbalance is common in children with pneumonia,which is closely associated with digestive health and disease recovery.Intestinal microecological imbalance may affect digestive enzyme activity,intestinal mucosal barrier function,and nutrient absorption,which in turn affects digestive health.In addition,intestinal microecological imbalances may be associated with immune regulation,inflammatory responses,and pathogen suppression,affecting disease recovery.Strategies to regulate intestinal microecology include probiotic supplementation,dietary modification,and pharmacological treatment.Currently,the study of intestinal microecology in children with pneumonia faces challenges,and there is a need for improved research methods,individualized treatment strategies,and the development of novel probiotics.In conclusion,the intestinal microecology of children with pneumonia is closely related to digestive health and disease recovery,and the regulation of intestinal microecology is of great significance to the treatment of children with pneumonia.Furthermore,future research should further explore the application of the microecology of the intestinal microecology in the treatment of children with pneumonia.

The Effect of Azithromycin in Treating Mycoplasma Pneumonia in Children

Objective:To discuss and analyze the effect of azithromycin in the treatment of mycoplasma pneumonia in children.Methods:A total of 120 children with mycoplasma pneumonia who were admitted to the Department of Pediatrics of our hospital from January 2022 to December 2022 were selected as the research subjects.They were divided into an azithromycin group and a reference group according to the random number drawing method,with 60 cases in each group.The azithromycin group was treated with azithromycin,and the reference group was treated with conventional treatment.The efficacy of treatment,laboratory indicators,platelet count and D-dimer,and adverse reactions of both groups were compared.Results:The efficacy of the azithromycin group was significantly higher than that of the reference group(P<0.05).Before treatment,there were no significant differences in the laboratory indicators like ferritin,procalcitonin(PCT),and erythrocyte sedimentation rate(ESR)between the two groups(P>0.05);after treatment,the laboratory indicators of the azithromycin group were significantly better than those of the reference group(P<0.05).Before treatment,there was no statistically significant difference in platelet count and D-dimer between the groups(P>0.05);after medication,the platelet count,and D-dimer in the azithromycin group were significantly better than those in the reference group(P<0.05).The total incidence of adverse reactions in the azithromycin group was significantly lower than that in the reference group(P<0.05).Conclusion:Azithromycin is more effective in treating mycoplasma pneumonia in children,and has certain clinical value.

Analysis on the Clinical Effect of Shenling Baizhu San Combined with Routine Treatment on Bacterial Pneumonia in Children

[Objectives]To explore the effect of Shenling Baizhu San combined with routine treatment on the clinical efficacy,gastrointestinal function protection,inflammatory response and immune function of children with bacterial pneumonia.[Methods]From July 2017 to January 2018,80 children with bacterial pneumonia were randomly selected and divided into observation group and control group with 40 cases in each group.The control group was treated with conventional Western medicine,while the observation group was treated with Shenling Baizhu San on the basis of conventional treatment,with a period of 10 d.Then,we compared the clinical efficacy,incidence of gastrointestinal symptoms,WBC,CRP,CD4+and CD8+levels between the two groups.[Results]The clinical efficacy of the observation group was better than that of the control group(P<0.05).After treatment,the levels of WBC and CRP in the two groups decreased,especially in the observation group(P<0.05).After treatment,the level of CD4+in both groups increased significantly,while the level of CD8+decreased significantly,and the level of CD4+in the observation group was significantly higher than that in the control group after treatment.The incidence of gastrointestinal symptoms in the observation group was significantly lower than that in the control group(P<0.01).[Conclusions]Shenling Baizhu San can obviously improve the clinical effect of bacterial pneumonia in children and has the protective effect of gastrointestinal tract,and its mechanism may be related to its anti-inflammatory and immunomodulatory effects.

Diagnostic Value of the Thoracic Ultrasonography Compared to Conventional Chest X-Rays in Pneumonia for Children between 0 to 15 Years: Case Study in Two Hospitals in Yaoundé

Introduction: The diagnosis of pneumonia is usually made based on clinical manifestations and chest X-ray. The use of ultrasound in detecting pulmonary diseases in general, and especially consolidation syndrome has been demonstrated. The objective of this study was to determine the accuracy of thoracic ultrasound compared to chest X-ray in the diagnosis of infectious pneumonia in children. Methods: Children between 0 to 15 years were included in our study. The lung ultrasound results obtained were compared with those of the chest X-ray used as the reference. Our data were introduced into the EpiInfo 3.5.4 software and analyzed with the EpiInfo 3.5.4 and IBMSPSS Statistics version 20.0 softwares. Microsoft Office Excel 2016 was used to produce Charts. Continuous quantitative variables were presented. Cohen’s Kappa concordance test was applied with confidence interval of 95%. Results: 52 children were enrolled in the study. In imaging, the dominant sign was consolidation syndrome (75.0%) of cases by chest radiography, and in 78.8% of cases by lung ultrasound (p Conclusion: Our study demonstrated that lung echography is a non-ionizing and reliable tool in the diagnosis of childhood’s pneumonia.

Acute Pneumonia Characteristics in Children under Five Years of Age in Bamako, Mali

Pneumonia is the most common cause of mortality in child under five years of age. The objective of the study was to assess socio-demographic and clinical characteristics of children under 5 hospitalized for pneumonia. Material and method: We conducted a 6 months prospective study from June 1st, 2016 to December 31st, 2016 in the general pediatric service in the Pediatric Department of Gabriel Touré Teaching Hospital in Bamako, the capital city of Mali. Result: We have selected 63 cases of pneumonia according to our definition criteria, i.e. 2.2% of hospitalizations for children aged 1 to 59 months. The average age was 14 months. Infants under 2 years accounted for 82.53%. The sex ratio was 1.2. Seventy eight percent came from an unfavorable socio-economic background. The majority of mothers were uneducated (71.42%). Breastfeeding was exclusive up to 6 months in 50.79% of patients. Vaccination according to the national program was not up to date in 27% of patients. The average consultation time was 18 days. On admission, 81% of the patients had a fever, 93.64% had a tachypnea and 58.73% had crackling rales at pulmonary auscultation. Hypoxemia was present in 58.73%. Severe anemia was present in 79.36%. Radiologically, opacity was found in 42 patients (66.66%). The blood culture was positive in 8.3%. Beta-lactams were first-line prescribed in all patients. The case fatality rate was 9.52%. The factors associated with mortality were age less than 14 months (p = 0.08), adverse socio-economic conditions (p = 0.0003) and the presence of hypoxemia at the entrance (p = 0.01). Conclusion: Pneumonia remains major cause of morbidity and mortality in our context. Emphasis should be put on preventive measures.

Atypical pathogens in community acquired pneumonia of Egyptian children

Objective:Diagnosis of atypical pathogens as an aetiology for community-acquired pneumonia(CAP) in children is a challenge world wide.The aim of this study was to detect the frequency of atypical pathogens as a cause of community-acquired pneumonia(CAP) in Egyptian children.Methods:From 50 children(with age ranged from 2 months to 12 years) hospitalized for community-acquired pneumonia;respiratory sputum samples were collected by induction or spontaneously.All samples were subjected to conventional cultures and Polymerase Chain Reaction(PCR) technique DNA extraction for identification of Mycoplasma,Chlamydia pneumoniae and Legionella pneumophila.Results;A definite pathogen was identified in 78%of the studied children;30% typical bacteria,8%Candida albicans and atypical bacteria in 40%of the pneumonic children.Chlamydia pneumoniae was isolated from 26%of the children while Mycoplasma pneumoniae was isolated from 14%, whereas Legionella pneumophilla was not isolated at all.Conclusion;Atypical pathogens are evident as a potential aetiology for community-acquired pneumonia in(13.3%) of young and(80%) of older Egyptian children.

Pneumonia of Children under 5 Years of Age in Brazzaville (Republic of Congo)

Pneumonia is one of the prime causes of morbidity and mortality in children under five years of age. Objectives: To determine the frequency of pneumonia, to identify the causative organisms and the factors associated with death in children under 5 years of age. Methods: A prospective cohort study was performed in children 1 to 59 months hospitalized for pneumonia between January and June 2016 in CHUB pediatric wards. Results: A total of 237 children were hospitalized for pneumonia, i.e. 12.3% of hospitalizations. There were 133 boys (56%) and 104 girls (44%) with a mean age of 15.9 ± 13.8 months. The average time elapsed between onset of symptoms and hospitalization was 7.2 ± 6.1 days. The alveolar syndrome 185 cases (81%), alveolo-interstitial 34 cases (15%), alveolar and pleural 9 cases (4%) were the main radiological translations. Blood cultures were positive in 74 cases (31%) and the bacteria identified were: Streptococcus pneumoniae 42 cases (17.5%), Staphylococcus Aureus 23 cases (9.6%) and Klebsiella pneumoniae 9 cases (3.7%). HIV serology was positive in 19 cases (8%). Fifty-eight (58) children (24%) died. Factors associated with death were respiratory distress, hypoxemia and hypothermia. Conclusion: Pneumonia of children under 5 years of age is frequent and severe prognosis. Their mastery requires the strengthening of the national respiratory disease control program and the knowledge of risk factors.

Should Empyema with or without Necrotizing Pneumonia in Children Be Managed Differently?

Background: Necrotizing pneumonia (NP) is an increasing lung infection mostly associated with pleural empyema. Objectives: We aimed to compare children with empyema with and without concomitant NP, in terms of risk factors, management and outcome. Methods: We retrospectively included children hospitalized between 2005-2014 with empyema to whom a computed tomography was performed. We recorded patient characteristics, clinical, biological (blood and pleural fluid) and radiological findings, medical and surgical treatments, and clinical, radiological and functional follow-up. Results: 35 children with empyema were included, including 25 with a concomitant NP. Patients with or without NP were undistinguishable, in terms of characteristics, symptoms at admission or detected pathogens. Pleural leucocytes were significantly higher in the empyema group (p = 0.0002) as pleural LDH (p = 0.002), and pleural/blood LDH ratio (p = 0.0005). Medical and surgical managements were similar between both groups. Complications occurred in 1/10 children with empyema alone (pneumatocele) and 5/25 with concomitant NP (bronchopleural fistula (n = 3), lobectomy, pneumothorax). The hospital length of stay and delay for chest X-ray normalization were similar in both groups. Conclusion: Except for minor biological parameters, the presence of concomitant NP in case of empyema does not change the presentation, clinical features, management and outcome, suggesting that the presence of additional NP to empyema should not be managed differently. Therefore, in case of empyema with suspected concomitant NP, chest CT should probably be restricted to abnormal worsening or when mandatory for surgical treatment.

History of Vitamin A Supplementation Reduces Severity of Diarrhea in Young Children Admitted to Hospital with Diarrhea and Pneumonia

Background: Although the role of vitamin A in childhood pneumonia in association with diarrhea is not fully proven, we did not find any published data demonstrating the impact of lack of vitamin A supplementation in under-five children who present with the co-morbidities of pneumonia and diarrhea. This study examined whether previous vitamin A supplementation was associated with reduced severity and duration of diarrhea and pneumonia for children presenting with both illnesses. Methods: All admitted children (n = 189) aged 0 - 59 months to the Special Care Ward of the Dhaka Hospital of icddr,b with diarrhea and radiological pneumonia from September-December 2007 were enrolled. We compared clinical features of the children who received (n = 96) and did not receive (n = 93) high potency capsule vitamin A supplementation during previous immunization according to EPI schedule. Results: In logistic regression analysis, after adjusting for potential confounders such as respiratory rate, lower chest wall in-drawing, severe wasting and systolic blood pressure, vitamin A non-supplemented children with pneumonia and diarrhea more often presented in their early infancy (95% CI 1.01 - 1.09), had duration of diarrhea for >4 days (95% CI 1.79 - 11.88), had clinical dehydration (95% CI 1.2 - 5.63), and more often required hospitalization for >7 days (95% CI 1.03 - 8.87). But, there was no significant difference in the clinical features of pneumonia, such as history of cough, respiratory rate, lower chest wall in-drawing, nasal flaring, head nodding, grunting respiration, cyanosis, and inability to drink between the groups. Conclusion: Lack of vitamin A supplementation in under-five children with radiological pneumonia and diarrhea is independently associated with young infancy, duration of diarrhea for >4 days, dehydration and hospitalization for >7 days which underscores the importance of routine supplementation of vitamin A in young infancy. However, lack of vitamin A supplementation did not influence any clinical signs of pneumonia.

Predictive Factors of Hyponatremia in Under-Five Severely Malnourished Children with Pneumonia Admitted to a Large Urban Hospital in Dhaka, Bangladesh: A Nested Case-Control Design

Background: Hyponatremia is the most common electrolyte imbalance encountered in the management of diarrheal children. Common ramifications include cerebral edema and fatal outcomes. However, pediatric data remain lacking, particularly in developmental contexts where resources are limited and associated conditions like malnutrition and pneumonia are common. Aim: This study aimed to evaluate predicting factors associated with hyponatremia in children under five years of age with severe acute malnutrition (SAM) in Bangladesh. Methods: Using a nested case-control design, we compared clinical and laboratory characteristics of children with (n = 61) and without hyponatremia (n = 183) taken from a parent population of all children under five with SAM and clinical or radiological pneumonia admitted to Dhaka Hospital of icddr,b between April 2011 and June 2012 (n = 407). Results: Logistic regression analysis adjusting for potential confounders such as lack of breast feeding, duration of vomiting (days), and severe wasting revealed that older age (OR 1.05, 95%CI 1.02 - 1.07, p = 0.001) (5% increase in the relative odds of hyponatremia for each additional month of age), presence of diarrhea (OR 2.43, 95%CI 1.0 - 6.0, p = 0.05), and difficulty breathing (OR 1.52, 95%CI 1.0 - 2.05, p = 0.05) were significantly associated with hyponatremia. Conclusion: Our data suggest that older age, presence of diarrhea, and difficulty breathing in under-five children with SAM is independent predictors of hyponatremia. These findings underscore the importance of detecting simple clinical predictors early in order to facilitate appropriate management and to prevent potential ramifications of hyponatremia in SAM children, especially in resource-poor settings.

儿童重症肺炎支气管肺泡灌洗液的病原菌及药敏试验分析

目的了解儿童重症肺炎支气管肺泡灌洗液(BALF)的病原菌及药敏试验情况。方法选取该院2021年1月至2023年4月收治的100例重症肺炎患儿作为研究对象,对所有患儿进行支气管镜肺泡灌洗,并分析其BALF病原菌及药敏试验情况。结果100例患儿BALF中共培养出病原菌131株,革兰阴性菌98株(74.81%),革兰阳性球菌33株(25.19%),其中流感嗜血杆菌(25.19%)、肺炎链球菌(21.37%)占比较高,卡他布兰汉菌(15.27%)、肺炎克雷伯菌(11.45%)其次。重症肺炎患儿BALF中前4位病原菌主要以<1岁(97.37%)、1~3岁(96.88%)占比较高,>3~7岁(94.12%)、>7~14岁(92.31%)相对较少。各年龄BALF中流感嗜血杆菌、卡他布兰汉菌、肺炎克雷伯菌分布情况比较,差异均无统计学意义(P>0.05);各年龄BALF中肺炎链球菌分布情况比较,差异有统计学意义(P<0.05)。20株流感嗜血杆菌对四环素、阿莫西林-克拉维酸、头孢噻肟、复方磺胺甲噁唑均较敏感,对氯霉素敏感性其次,对氨苄西林、头孢克洛、头孢呋辛耐药性均较高;15株卡他布兰汉菌对头孢噻肟较敏感,对氨苄西林耐药性最高;8株肺炎克雷伯菌对头孢噻肟较敏感,对氨苄西林、头孢呋辛、氯霉素耐药性均较高,对阿莫西林-克拉维酸、四环素耐药性其次;20株肺炎链球菌对万古霉素、氯霉素均较敏感,对青霉素G、泰利霉素敏感性其次,对复方磺胺甲噁唑耐药性较高,对四环素、头孢噻肟、克林霉素耐药性其次。结论儿童重症肺炎BALF中病原菌以流感嗜血杆菌、肺炎链球菌多见,且0~3岁患儿病原菌占比高于>3~14岁,临床应合理用药以预防耐药菌株产生。

Status of <i>Mycoplasma pneumoniae</i>Pneumonia in Chinese Children: A Systematic Review

Mycoplasma pneumoniae pneumonia (MPP) becomes one of the most important health problems in China recently. Date for MPP inChinais scarce. Although macrolides and/or cortical steroids had been reported to be effective treatment for MPP, the long-term outcome remained uncertain. A study on status of MPP in China was conducted via a systematic review of published studies which have the Chinese data and collected from published PubMed and core journals of China Knowledge Resource Integrated Database (CNKI). The analysis was based on epidemiology, clinical characteristics, treatment, drug resistance and prognosis. Twenty five articles concerned about MPP in Chinese children and adolescent were enrolled, including 11 studies on epidemiology/etiology, 11 studies on clinical characteristics, 7 studies on drug resistance, 5 studies on treatment from China's Mainland respectively. The overall incidence of MPP ranged from 7.1% to 54.4%. Fever and cough were most frequently identified in manifestations. Drug resistance to macrolides ranged from 18.9% to 90%. The outcome of treatment in patients who received combined treatment of macrolides, cephalosporin antibiotics and/or cortical steroid seems to be better than those who received macrolides only. Macrolide combined with cephalosporin or cortical steroid both may decrease the severity of MPP in the past decade. There was not enough evidence to suggest that cortical steroid can decrease the mortality of MPP in children. And a multi-center, randomized double blind research on the effect of cortical steroid was encouraged.

金花清感颗粒联合布地奈德、沙丁胺醇、异丙托溴铵三联雾化吸入疗法在儿童肺炎支原体肺炎中的应用观察

目的分析金花清感颗粒联合布地奈德、沙丁胺醇、异丙托溴铵三联雾化吸入治疗儿童肺炎支原体肺炎(MPP)的效果。方法前瞻性选取2022年2月—2023年2月常熟市第二人民医院收治的114例MPP患儿为研究对象,按照随机数字表法分为对照组、研究组,每组57例。对照组给予布地奈德、沙丁胺醇、异丙托溴铵三联雾化吸入治疗,研究组在对照组基础上给予金花清感颗粒,连续治疗10 d评估效果。比较两组症状改善情况、肺功能、临床疗效、气道重塑指标、炎症因子、T淋巴细胞亚群及药物不良反应发生情况。结果研究组发热消退时间、咳嗽消失时间、肺部啰音消失时间均短于对照组(P<0.05)。研究组治疗前后的达峰时间比、达峰容积比、呼吸频率的差值均高于对照组(P<0.05)。研究组总有效率高于对照组(P<0.05)。研究组治疗前后的气道壁厚度/外径比值、气道面积/总横截面积比值的差值均高于对照组(P<0.05)。研究组治疗前后的超敏C反应蛋白、白细胞介素-6、肿瘤坏死因子-α的差值均高于对照组(P<0.05)。研究组治疗前后的CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+)的差值均高于对照组(P<0.05)。两组总不良反应发生率比较,差异无统计学意义(P>0.05)。结论金花清感颗粒联合布地奈德、沙丁胺醇、异丙托溴铵三联雾化吸入治疗儿童MPP疗效显著,可改善肺功能,抗气道重塑,抑制炎症反应,改善T淋巴细胞亚群,且安全性良好。

血清PCT、CRP及IL-4水平预测小儿支原体肺炎病情严重程度的价值

目的:探讨血清降钙素原(PCT)、C反应蛋白(CRP)及白细胞介素-4(IL-4)水平预测支原体肺炎患儿病情严重程度的价值。方法:选取2019年1月—2023年1月淮安市第二人民医院儿科收治的102例支原体肺炎患儿作为研究对象,根据病情将患儿分为轻症组59例和重症组43例。比较两组临床资料及基质细胞衍生因子(CXCL12)、γ干扰素(IFN-γ)、硫化氢(H_(2)S)、超氧化物歧化酶(SOD)、基质金属蛋白酶-9(MMP-9)、PCT、CRP及IL-4水平,多因素分析采取非条件logistic逐步回归分析,采用ROC曲线分析PCT、CRP及IL-4水平对重症支原体肺炎的预测价值。结果:两组性别、年龄、病程及CXCL12、IFN-γ、H_(2)S、SOD、MMP-9水平比较,差异无统计学意义(P>0.05);重症组PCT、CRP、IL-4水平显著高于轻症组,差异有统计学意义(P<0.05)。logistic逐步回归分析结果显示,PCT、CRP及IL-4为重症支原体肺炎独立危险因素(P<0.05)。ROC分析显示,PCT、CRP及IL-4预测重症支原体肺炎的曲线下面积分别为0.896、0.851、0.787。结论:血清PCT、CRP及IL-4水平均参与支气管肺炎患儿的病情进展,且可作为重症支气管肺炎的诊断指标。

经鼻加温湿化高流量氧疗对重症肺炎患儿血气指标、MMP-9及TNF-α的影响

目的 探讨经鼻加温湿化高流量氧疗(HFNC)治疗小儿重症肺炎的疗效及对血气指标、基质金属蛋白酶9(MMP-9)、肿瘤坏死因子α(TNF-α)的影响。方法 选取2018年5月—2020年8月河北省人民医院收治的123例重症肺炎患儿作为研究对象,按照随机抽样法分为观察组(HFNC治疗,n=62)与对照组(面罩吸氧治疗,n=61)。对比两组临床症状、动脉血二氧化碳分压(PaCO_(2))、血氧分压(PaO_(2))、TNF-α、MMP-9、血氧饱和度/吸入氧浓度与呼吸频率的比值(ROX指数)。结果 观察组的退热时间、体征消失时间、咳嗽咳痰消失时间、住院时间分别为(5.21±1.02)d、(10.02±1.32)d、(7.41±0.96)d、(9.02±2.69)d,均短于对照组(t=5.688、10.332、10.253、2.180,P<0.05)。观察组治疗后2、6、12、24 h的ROX指数分别为(6.31±1.62)、(9.85±1.96)、(11.65±2.39)、(13.46±3.25),均高于对照组(t=2.467、3.380、4.251、4.902,P<0.05);治疗后,观察组的PaCO_(2)(35.69±5.21)mmHg低于对照组,而PaO_(2)(87.52±18.69)mmHg高于对照组(t=2.379、4.647,P<0.05);治疗后,观察组的MMP-9、TNF-α分别为(6.32±1.05)pg/mL、(10.40±1.30)pg/mL,低于对照组(t=13.425、13.060,P<0.05)。结论 HFNC用于重症肺炎患儿中具有显著效果,有利于改善患儿血气指标,降低MMP-9、TNF-α水平。

阿奇霉素联合头孢哌酮舒巴坦治疗小儿细菌性肺炎的效果分析

目的:分析阿奇霉素联合头孢哌酮舒巴坦治疗小儿细菌性肺炎的效果。方法:选取2017年2月—2023年2月北京丰台医院收治的66例细菌性肺炎患儿作为研究对象,根据随机数字表法分为观察组和对照组,各33例。两组均给予常规治疗,对照组在常规治疗基础上给予头孢哌酮舒巴坦治疗,观察组在对照组基础上给予阿奇霉素治疗。比较两组症状体征持续时间、胸部CT病灶持续时间、住院时间、D-二聚体(D-D)水平和炎性因子水平。结果:观察组发热持续时间、喘息持续时间、咳嗽持续时间、肺部啰音持续时间、胸部CT病灶持续时间及住院时间短于对照组,差异有统计学意义(P<0.001)。治疗前,两组D-D、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)水平比较,差异无统计学意义(P>0.05);治疗后,两组D-D、TNF-α、IL-6、IL-8水平低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。结论:阿奇霉素联合头孢哌酮舒巴坦治疗小儿细菌性肺炎的效果较好,可加速缓解症状,减轻炎性反应,促进康复。

核酸检测与抗体测定对儿童肺炎支原体感染的诊断价值

目的探究肺炎支原体核酸检测(MP-DNA、MP-RNA)与肺炎支原体抗体测定(MP-IgM)对儿童肺炎支原体感染的诊断价值。方法收集2023年11月至2024年2月医院收治的201例呼吸道疾病患儿的外周血标本和咽拭子,分别采用荧光核酸恒温扩增检测技术检测MP-RNA、取-70℃冻存后咽拭子标本,采用实时荧光定量PCR方法检测MPDNA、采用胶体金免疫层析法检测MP-IgM,将MP-DNA、MP-IgM与金标准(MP-RNA)进行比较,统计检测结果的一致性。结果MP-DNA灵敏度为89.47%,特异度为97.55%,与MPRNA检测结果一致性极好(Kappa=0.87)。MP-IgM灵敏度为34.21%,特异度为93.87%,与MP-RNA检测结果一致性较差(Kappa=0.33)。结论MP-DNA与MP-IgM相比,在肺炎支原体的诊断中具有更高的应用价值,特别是感染初期。对于满足门、急诊对实验室报告及时、高效的需求,可考虑抗体测定与核酸检测法相结合,提高实验室对肺炎支原体的诊断能力。

儿童肺炎支原体肺炎的病理及影像学表现特点

肺炎支原体肺炎(mycoplasma pneumoniae pneumonia,MPP)是我国儿童社区获得性肺炎中最常见的类型,早期识别危重症病例、合理救治、减少后遗症是MPP诊治的关键。MPP发病机制在于肺炎支原体对呼吸道的直接损伤和宿主异常免疫应答,病理表现包括肺气道及肺间质炎、塑形性支气管炎、肺泡炎性渗出、坏死性肺炎、肺栓塞及胸腔积液等。影像学对MPP病情严重程度判断和预后评估有重要作用。MPP影像学表现主要有塑形性支气管炎、树芽征、小叶中心结节、树雾征、肺实变、肺坏死、肺栓塞、胸腔积液等。其中,肺坏死和肺栓塞是诊断重症MPP的重要指征。肺坏死临床症状以持续高热和C反应蛋白明显升高为特点。肺栓塞表现包括胸痛和/或咯血、D-二聚体升高和血性胸腔积液。本文结合相关研究进展,通过图文解析MPP影像学表现、相关的发病机制及病理表现,总结各影像学征象与MPP临床特点的关系,旨在提高儿科医生和放射科医生对儿童MPP的认识。

辨证推拿辅助治疗小儿难治性支原体肺炎的效果观察

目的分析辨证推拿辅助治疗小儿难治性支原体肺炎(RMPP)对炎症指标、肺功能的影响。方法选择河北省第七人民医院2022年9月—2023年8月就诊的320例RMPP患儿为研究对象,根据治疗方法不同将其分为2组,每组160例。西医组给予常规抗炎等对症治疗,推拿组在西医组基础上给予辨证推拿治疗。比较2组临床疗效、临床症状消失时间、肺功能指标、血清炎症因子、免疫功能指标、不良反应总发生率。结果推拿组临床总有效率高于西医组,差异有统计学意义(P<0.05)。推拿组发热、咳嗽、咳痰、肺部湿啰音消失时间均较西医组更短,差异有统计学意义(P<0.05)。推拿组治疗后最大呼气流量(PEF)、最大呼气中期流量(MMEF)、用力肺活量(FVC)均较西医组更高,血清C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平均较西医组更低,差异有统计学意义(P<0.05)。推拿组治疗后CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)均较西医组更高,CD8^(+)较西医组更低,差异有统计学意义(P<0.05)。推拿组不良反应总发生率与西医组比较,差异无统计学意义(P>0.05)。结论辨证推拿联合西药可有效缓解RMPP患儿发热、咳嗽等症状,减轻炎症反应,改善肺功能及免疫功能,且不良反应较少。